Hepatic resection for metachronous metastases from ovarian carcinoma

Gynecologic Oncology

Volumn 89, Issue 1, 2003, Pages 16-21

  Merideth, Melissa A ^a   Cliby, William A ^a   Keeney, Gary L ^a   Lesnick, Timothy G ^a   Nagorney, David M ^a   Podratz, Karl C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cytoreduction; Liver; Morbidity; Mortality; Retrospective study

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CANCER DIAGNOSIS; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; HUMAN; HUMAN TISSUE; INTESTINE PERFORATION; LIVER METASTASIS; LIVER RESECTION; MEDICAL RECORD; MIXED MULLERIAN TUMOR; MORBIDITY; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; RETROSPECTIVE STUDY; SURGICAL MORTALITY; WOUND INFECTION;

EID: 0037386240     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(03)00004-0     Document Type: Article

References (15)

1. Eisenkop S.M., Friedman R.L., Wang J.H. Secondary cytoreductive surgery for recurrent ovarian cancer a prospective study . Cancer. 76:1995;1606-1614.
2. Williams L., Brunetto V.L., Yordan E., DiSaia P.J., Creasman W.T. Secondary cytoreductive surgery at second-look laparotomy in advanced ovarian cancer a Gynecologic Group Study . Gynecol Oncol. 66:1997;171-178.
3. Garden O.J., Geraghty J.G., Nagorney D.M. Liver metastases biology, diagnosis, and treatment . 1998;Springer, London.
4. Bristow R.E., Montz F.J., Lagasse L.D., Leuchter R.S., Karlan B.Y. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Gynecol Oncol. 72:1999;278-287.
5. Chi D.S., Fong Y., Venkatraman E.S., Barakat R.R. Hepatic resection for metastatic gynecologic carcinomas. Gynecol Oncol. 66:1997;45-51.
6. Nagorney D.M. Hepatic resections. Chassin J.L. Operative strategy in general surgery an expositive atlas . 2nd ed:1994;585-598 Springer-Verlag, New York.
7. Nagorney D.M. Hepatic resections. Donohue J.H., van Heerden J.A., Monson J.R.T. Atlas of surgical oncology. 1995;189-200 Blackwell Science, Cambridge, MA.
8. Nagorney D.M. Surgery for benign and malignant tumors of the liver. Bland K.I., Karakousis C.P., Copeland E.M. III. Atlas of surgical oncology. 1995;455-472 Saunders, Philadelphia.
9. Kaplan E., Meier P. Nonparametric estimation for incomplete observations. J Am Stat Assoc. 53:1958;457-481.
10. Lawless J.F. Statistical models and methods for lifetime data. 1982;Wiley, New York.
11. Hacker N.F., Berek J.S., Lagasse L.D., Nieberg R.K., Elashoff R.M. Primary cytoreductive surgery for epithelial ovarian cancer. Obstet Gynecol. 61:1983;413-420.
12. Griffiths C.T. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr. 42:1975;101-104.
13. Delgado G., Oram D.H., Petrilli E.S. Stage III epithelial ovarian cancer the role of maximal surgical reduction . Gynecol Oncol. 18:1984;293-298.
14. Liu P.C., Benjamin I., Morgan M.A., King S.A., Mikuta J.J., Rubin S.C. Effect of surgical debulking on survival in stage IV ovarian cancer. Gynecol Oncol. 64:1997;4-8.
15. Scarabelli C., Gallo A., Carbone A. Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma. Gynecol Oncol. 83:2001;504-512.